• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Red Abbey Venture Partners

edit

Red Abbey Venture Partners is a life sciences investment firm that was founded in 2004. Since that time, it has invested in 15 privately held and 9 publicly traded life sciences companies. Mission is to generate superior, risk-adjusted returns by investing in young companies that are developing the next generation of drugs and devices, as well as companies that are supporting these efforts with novel tools and products. Specifically, seeking to invest across the life sciences spectrum, which includes biotechnology, specialty pharmaceutical, medical device, diagnostics and research tools companies.

Recent Milestones

edit

• 
  Red Abbey Venture Partners invested in Corridor Pharmaceuticals. (6/16/10)
  Posted 7/8/10 at 7:56pm via yahoo.com
• 
  Red Abbey Venture Partners invested in Oxagen. (11/24/09)
  Posted 11/25/09 at 4:32am via fiercebiotech.com
• 
  Red Abbey Venture Partners invested in Arginetix. (11/2/09)
  Posted 11/2/09 at 9:01pm via onbiovc.com
• 
  Red Abbey Venture Partners invested in Arginetix. (10/23/08)
  Posted 6/18/09 at 12:34am via findarticles.com
• 
  Red Abbey Venture Partners invested in Stromedix. (4/21/08)
  Posted 6/3/09 at 10:22pm
• 
  Red Abbey Venture Partners invested in Advanced BioHealing. (2/27/07)
  Posted 3/11/10 at 11:03pm via abh.com
• 
  Red Abbey Venture Partners invested in MacroGenics. (5/17/06)
  Posted 4/19/10 at 11:38pm via macrogenics.com
• 
  Red Abbey Venture Partners invested in Anacor Pharmaceutical. (5/11/05)
  Posted 7/2/10 at 1:34am via anacor.com

Investments

Videos

Sources

1. Arginetix and Immune Control Merge to Form Corridor Pharmaceuticals (finance.yahoo.com) [edit]
2. Oxagen rounds up $26.7M in VC (fiercebiotech.com) [edit]
3. Arginetix, Inc.: Series B $4.6M (onbiovc.com) [edit]
4. Arginetix, Inc. Completes $2.3 Million Initial Financing and Technology License (findarticles.com) [edit]
5. Capital Funding Report [edit]
6. Advanced BioHealing Raises $25.5 Million in Series C Financing (abh.com) [edit]
7. MacroGenics Raises $45M in Series C Financing - Company to Advance Monoclonal Antibody Clinical Programs (macrogenics.com) [edit]
8. ANACOR PHARMACEUTICALS RAISES $25 MILLION IN SERIES C FINANCING (anacor.com) [edit]